Superior Bioavailability of a Novel Curcumin Formulation in Healthy Humans Under Fasting Conditions
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-8652
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Superior Bioavailability of a Novel Curcumin Formulation in Healthy Humans Under Fasting Conditions ; volume:39 ; number:5 ; day:16 ; month:3 ; year:2022 ; pages:2128-2138 ; date:5.2022
Advances in therapy ; 39, Heft 5 (16.3.2022), 2128-2138, 5.2022
- Creator
-
Kothaplly, Sudhakar
Alukapally, Shankar
Nagula, Nagaraju
Maddela, Rambabu
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12325-022-02081-w
- URN
-
urn:nbn:de:101:1-2022071011104486982743
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kothaplly, Sudhakar
- Alukapally, Shankar
- Nagula, Nagaraju
- Maddela, Rambabu
- SpringerLink (Online service)
Other Objects (12)
Superior Bioavailability of a Novel Lutein and Zeaxanthin Formulation in Healthy Human Subjects
Curcumin : bioavailability and bioactivity in relation to aging
Curcumin-resveratrol nano-formulation counteracting hyperammonemia in rats
Relative bioavailability of curcumin as affected by formulation strategies : from in vitro digestion and cell culture experiments to human clinical trials
ι-Carrageenan nanocomposites for enhanced stability and oral bioavailability of curcumin
Bioavailability of a Capsaicin Lipid Multi-particulate Formulation in Rats
Dasatinib anhydrate containing oral formulation improves variability and bioavailability in humans
Correction to: Bioavailability of a Capsaicin Lipid Multi‑particulate Formulation in Rats
Analysis of different innovative formulations of curcumin for improved relative oral bioavailability in human subjects
Formulation and evaluation of curcumin microsponges for oral and topical drug delivery
Formulation and characterization of nanofibrous scaffolds incorporating extracellular vesicles loaded with curcumin
Clinical trials on curcumin in relation to its bioavailability and effect on malignant diseases: critical analysis
Superior Bioavailability of a Novel Lutein and Zeaxanthin Formulation in Healthy Human Subjects
Curcumin : bioavailability and bioactivity in relation to aging
Curcumin-resveratrol nano-formulation counteracting hyperammonemia in rats
Relative bioavailability of curcumin as affected by formulation strategies : from in vitro digestion and cell culture experiments to human clinical trials
ι-Carrageenan nanocomposites for enhanced stability and oral bioavailability of curcumin
Bioavailability of a Capsaicin Lipid Multi-particulate Formulation in Rats
Dasatinib anhydrate containing oral formulation improves variability and bioavailability in humans
Correction to: Bioavailability of a Capsaicin Lipid Multi‑particulate Formulation in Rats
Analysis of different innovative formulations of curcumin for improved relative oral bioavailability in human subjects
Formulation and evaluation of curcumin microsponges for oral and topical drug delivery
Formulation and characterization of nanofibrous scaffolds incorporating extracellular vesicles loaded with curcumin
Clinical trials on curcumin in relation to its bioavailability and effect on malignant diseases: critical analysis
Superior Bioavailability of a Novel Lutein and Zeaxanthin Formulation in Healthy Human Subjects
Curcumin : bioavailability and bioactivity in relation to aging
Curcumin-resveratrol nano-formulation counteracting hyperammonemia in rats
Relative bioavailability of curcumin as affected by formulation strategies : from in vitro digestion and cell culture experiments to human clinical trials
ι-Carrageenan nanocomposites for enhanced stability and oral bioavailability of curcumin
Bioavailability of a Capsaicin Lipid Multi-particulate Formulation in Rats
Dasatinib anhydrate containing oral formulation improves variability and bioavailability in humans
Correction to: Bioavailability of a Capsaicin Lipid Multi‑particulate Formulation in Rats
Analysis of different innovative formulations of curcumin for improved relative oral bioavailability in human subjects
Formulation and evaluation of curcumin microsponges for oral and topical drug delivery
Formulation and characterization of nanofibrous scaffolds incorporating extracellular vesicles loaded with curcumin